Terms: = Endocrine gland cancer AND ETV5, P41161, 2119, ENSG00000244405, ERM
41 results:
1. etv5 Silencing Produces Mesenchymal to Epithelial Transition in INS-1 (832/13) Cell Line.
Díaz-López YE; Cázares-Domínguez V; Arenas-Huertero F; Gutierrez-Aguilar R
Horm Metab Res; 2024 Mar; 56(3):235-243. PubMed ID: 38335994
[TBL] [Abstract] [Full Text] [Related]
2. Moesin affects the plasma membrane expression and the immune checkpoint function of CD47 in human ovarian clear cell carcinoma.
Ito Y; Kobori T; Urashima Y; Ito T; Hotta K; Obata T
J Reprod Immunol; 2024 Feb; 161():104185. PubMed ID: 38141516
[TBL] [Abstract] [Full Text] [Related]
3. Prevalence of 'Fat-Poor' Adrenal Adenomas at Chemical-Shift MRI.
Aldhufian M; Sheinis Pickovsky J; Alfaleh H; Melkus G; Schieda N
Can Assoc Radiol J; 2024 Feb; 75(1):98-106. PubMed ID: 37335612
[TBL] [Abstract] [Full Text] [Related]
4. Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study.
Medas F; Dobrinja C; Al-Suhaimi EA; Altmeier J; Anajar S; Arikan AE; Azaryan I; Bains L; Basili G; Bolukbasi H; Bononi M; Borumandi F; Bozan MB; Brenta G; Brunaud L; Brunner M; Buemi A; Canu GL; Cappellacci F; Cartwright SB; Castells Fusté I; Cavalheiro B; Cavallaro G; Chala A; Chan SYB; Chaplin J; Cheema MS; Chiapponi C; Chiofalo MG; Chrysos E; D'Amore A; de Cillia M; De Crea C; de Manzini N; de Matos LL; De Pasquale L; Del Rio P; Demarchi MS; Dhiwakar M; Donatini G; Dora JM; D'Orazi V; Doulatram Gamgaram VK; Eismontas V; Kabiri EH; El Malki HO; Elzahaby I; Enciu O; Eskander A; Feroci F; Figueroa-Bohorquez D; Filis D; François G; Frías-Fernández P; Gamboa-Dominguez A; Genc V; Giordano D; Gómez-Pedraza A; Graceffa G; Griffin J; Guerreiro SC; Gupta K; Gupta KK; Gurrado A; Hajiioannou J; Hakala T; Harahap WA; Hargitai L; Hartl D; Hellmann A; Hlozek J; Hoang VT; Iacobone M; Innaro N; Ioannidis O; Jang JHI; Xavier-Junior JC; Jovanovic M; Kaderli RM; Kakamad F; Kaliszewski K; Karamanliev M; Katoh H; Košec A; Kovacevic B; Kowalski LP; Králik R; Yadav SK; Kumorová A; Lampridis S; Lasithiotakis K; Leclere JC; Leong EKF; Leow MK; Lim JY; Lino-Silva LS; Liu SYW; Llorach NP; Lombardi CP; López-Gómez J; Lori E; Quintanilla-Dieck L; Lucchini R; Madani A; Manatakis D; Markovic I; Materazzi G; Mazeh H; Mercante G; Meyer-Rochow GY; Mihaljevic O; Miller JA; Minuto M; Monacelli M; Mulita F; Mullineris B; Muñoz-de-Nova JL; Muradás Girardi F; Nader S; Napadon T; Nastos C; Offi C; Ronen O; Oragano L; Orois A; Pan Y; Panagiotidis E; Panchangam RB; Papavramidis T; Parida PK; Paspala A; Pérez ÒV; Petrovic S; Raffaelli M; Ramacciotti CF; Ratia Gimenez T; Rivo Vázquez Á; Roh JL; Rossi L; Sanabria A; Santeerapharp A; Semenov A; Seneviratne S; Serdar A; Sheahan P; Sheppard SC; Slotcavage RL; Smaxwil C; Kim SY; Sorrenti S; Spartalis E; Sriphrapradang C; Testini M; Turk Y; Tzikos G; Vabalayte K; Vargas-Osorio K; Vázquez Rentería RS; Velázquez-Fernández D; Vithana SMP; Yücel L; Yulian ED; Zahradnikova P; Zarogoulidis P; Ziablitskaia E; Zolotoukho A; Calò PG;
Lancet Diabetes Endocrinol; 2023 Jun; 11(6):402-413. PubMed ID: 37127041
[TBL] [Abstract] [Full Text] [Related]
5. ANGPTL4 functions as an oncogene through regulation of the etv5/CDH5/AKT/MMP9 axis to promote angiogenesis in ovarian cancer.
Liu Y; Yang R; Zhang Y; Zhu Y; Bao W
J Ovarian Res; 2022 Dec; 15(1):131. PubMed ID: 36517864
[TBL] [Abstract] [Full Text] [Related]
6. Expansion of KRAS hotspot mutations reactive T cells from human pancreatic tumors using autologous T cells as the antigen-presenting cells.
Wang S; Zhang X; Zou X; Wen M; Gan C; Jiang X; Li M; Shen R; Zhu D; Yao A; Fang Y; Fox BA; Hu HM; Yu G; Wang X
Cancer Immunol Immunother; 2023 May; 72(5):1301-1313. PubMed ID: 36436020
[TBL] [Abstract] [Full Text] [Related]
7. O-GlcNAcylation regulates lysophosphatidic acid-induced cell migration by regulating erm family proteins.
Song M; Suh PG
FEBS Open Bio; 2022 Jun; 12(6):1220-1229. PubMed ID: 35347892
[TBL] [Abstract] [Full Text] [Related]
8. Biological and prognostic value of etv5 in high-grade serous ovarian cancer.
Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
[TBL] [Abstract] [Full Text] [Related]
9. Long-term survival outcome of advanced epithelial ovarian cancer: A single institutional study.
Viral P; Rajanbabu A; Pavithran K; Chithrathara K; Nair IR; Bhaskaran R; Gangadharan P; Vijaykumar DK
Indian J Cancer; 2021; 58(3):342-348. PubMed ID: 33402564
[TBL] [Abstract] [Full Text] [Related]
10. A New Device for Fine-Needle Aspiration Cytology Consisting of a Vibrating Linear Resonant Actuator.
Taguchi A; Kojima T; Okanoue Y; Kagoshima H; Hasebe K; Yamamoto H; Hori R
Laryngoscope; 2021 Apr; 131(4):E1393-E1399. PubMed ID: 33001466
[TBL] [Abstract] [Full Text] [Related]
11. etv5 overexpression contributes to tumor growth and progression of thyroid cancer through PIK3CA.
Meng D; Li Z; Ma X; Wu L; Fu L; Qin G
Life Sci; 2020 Jul; 253():117693. PubMed ID: 32325133
[TBL] [Abstract] [Full Text] [Related]
12. MiR-1307 influences the chemotherapeutic sensitivity in ovarian cancer cells through the regulation of the CIC transcriptional repressor.
Zhou Y; Wang M; Shuang T; Liu Y; Zhang Y; Shi C
Pathol Res Pract; 2019 Oct; 215(10):152606. PubMed ID: 31500928
[TBL] [Abstract] [Full Text] [Related]
13. ETS Factor etv5 Activates the Mutant Telomerase Reverse Transcriptase Promoter in Thyroid cancer.
Bullock M; Lim G; Zhu Y; Åberg H; Kurdyukov S; Clifton-Bligh R
Thyroid; 2019 Nov; 29(11):1623-1633. PubMed ID: 31452441
[No Abstract] [Full Text] [Related]
14. Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Song YS; Yoo SK; Kim HH; Jung G; Oh AR; Cha JY; Kim SJ; Cho SW; Lee KE; Seo JS; Park YJ
Endocr Relat Cancer; 2019 Jun; 26(6):629-641. PubMed ID: 30999281
[TBL] [Abstract] [Full Text] [Related]
15. Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma.
Penchev VR; Chang YT; Begum A; Ewachiw T; Gocke C; Li J; McMillan RH; Wang Q; Anders R; Marchionni L; Maitra A; Uren A; Rasheed Z; Matsui W
Mol Cancer Res; 2019 Apr; 17(4):929-936. PubMed ID: 30655325
[TBL] [Abstract] [Full Text] [Related]
16. Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases.
Sikorska J; Gaweł D; Domek H; Rudzińska M; Czarnocka B
BMC Cancer; 2019 Jan; 19(1):85. PubMed ID: 30654768
[TBL] [Abstract] [Full Text] [Related]
17. The Transcription Factor etv5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid cancer Cells.
Puli OR; Danysh BP; McBeath E; Sinha DK; Hoang NM; Powell RT; Danysh HE; Cabanillas ME; Cote GJ; Hofmann MC
Neoplasia; 2018 Nov; 20(11):1121-1134. PubMed ID: 30265861
[TBL] [Abstract] [Full Text] [Related]
18. LPA-induced migration of ovarian cancer cells requires activation of erm proteins via LPA
Park J; Jang JH; Oh S; Kim M; Shin C; Jeong M; Heo K; Park JB; Kim SR; Oh YS
Cell Signal; 2018 Apr; 44():138-147. PubMed ID: 29329782
[TBL] [Abstract] [Full Text] [Related]
19. Dynamic relocalization of NHERF1 mediates chemotactic migration of ovarian cancer cells toward lysophosphatidic acid stimulation.
Oh YS; Heo K; Kim EK; Jang JH; Bae SS; Park JB; Kim YH; Song M; Kim SR; Ryu SH; Kim IH; Suh PG
Exp Mol Med; 2017 Jul; 49(7):e351. PubMed ID: 28684865
[TBL] [Abstract] [Full Text] [Related]
20. Synthetic 8-hydroxydeoxyguanosine inhibited metastasis of pancreatic cancer through concerted inhibitions of erm and Rho-GTPase.
Park JM; Han YM; Jeong M; Chung MH; Kwon CI; Ko KH; Hahm KB
Free Radic Biol Med; 2017 Sep; 110():151-161. PubMed ID: 28602912
[TBL] [Abstract] [Full Text] [Related]
[Next]
